CVN14

CVN14 has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jan 29, 2026: “Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors”.

Intervention

1 paper studies it1 findingUpdated

PubChem

See all 1 papers on CVN14

At a glance

The findings reach cells, none yet in people. 1 lab in 3 countries.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 3 countries
  • Funder: Cerevance
  • 1 of 1 finding with company ties
  • Animals1

What did studies of CVN14 find?

1

Studies of CVN14 measured one outcome, CD38.

CD38

downin cells1

1 study
  1. CVN14 inhibits CD38 in cells.

    “culminating in the identification of CVN14, a potent, selective, and brain-penetrant tool molecule”

    Cells

    Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors

    ACS medicinal chemistry letters

More on CD38

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months